Concepedia

Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial

Dominique Baeten, Xenofon Baraliakos, Jürgen Braun, Joachim Sieper, Paul Emery, Désirée van der Heijde, Iain B. McInnes, Jacob M. van Laar, Robert Landewé, J. Wollenhaupt,

The Lancet · 2013 · 590 citations · 36 references

DOI

Concepts

References

36

Evaluation of Diagnostic Criteria for Ankylosing Spondylitis

Sjef van der Linden, Hans A. Valkenburg, A. Cats · Arthritis & Rheumatism · 1984 · 5.7K citations

, , +6

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.

Sylvester Garrett, T Jenkinson, L G Kennedy et al. · PubMed · 1994 · 3.2K citations

, , +12

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

Wolfgang Hueber, Bruce E. Sands, Steve Lewitzky et al. · Gut · 2012 · 1.5K citations · Full text

, , +15

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants

Paul R. Burton, Martin D. Tobin, Kate Elliott et al. · Nature Genetics · 2007 · 1.4K citations · Full text

, , +14

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

Jürgen Braun, J. Brandt, Joachim Listing et al. · The Lancet · 2002 · 1.3K citations

, , +7